DEVICE FOR ENHANCING TRANSDERMAL AGENT FLUX

(19)

(11)

EP 1 037 687 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	22.10.2008 Bulletin 2008/43

(45)	Mention of the grant of the patent:
	03.09.2008 Bulletin 2008/36

(21)	Application number: 98964712.8

(22)	Date of filing: 09.12.1998

(51)

International Patent Classification (IPC):

A61M 37/00^(2006.01)

A61N 1/30^(2006.01)

(86)	International application number:
	PCT/US1998/026156

(87)	International publication number:
	WO 1999/029298 (17.06.1999 Gazette 1999/24)

(54)	DEVICE FOR ENHANCING TRANSDERMAL AGENT FLUX VORRICHTUNG ZUR VERBESSERUNG DES TRANSDERMALEN FLUSSES VON MEDIKAMENTEN DISPOSITIF RENFOR ANT LE FLUX D'AGENTS TRANSDERMIQUES

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

11.12.1997 US 69339 P

(43)	Date of publication of application:
	27.09.2000 Bulletin 2000/39

(60)	Divisional application:
	08000212.4 / 1911488

(73)	Proprietor: ALZA Corporation
	Mountain View, CA 94043 (US)

(72)	Inventors:
	TRAUTMAN, Joseph, Creagan Sunnyvale, CA 94087 (US) WONG, Patrick, S.-L. Burlingame, CA 94010 (US) DADONNA, Peter, E. Menlo Park, CA 94025 (US) KIM, Hyunok, Lynn Walnut Creek, CA 91789 (US) ZUCK, Michael, G. Bend, OR 97701 (US)

(74)	Representative: Soames, Candida Jane
	EAPD Innovations 10 Carlton Crescent Southampton SO15 2EZ Southampton SO15 2EZ (GB)

(56)

References cited: :

WO-A-96/17648
WO-A-98/28037
US-A- 3 072 122

WO-A-96/37256
DE-A- 19 525 607
US-A- 3 964 482

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).